HY-13624A-50mg
|
MedChemexpress LLC
|
Epirubicin hydrochloride [CAS 56390-09-1]
|
|
|
|
HY-13624A-100mg
|
MedChemexpress LLC
|
Epirubicin hydrochloride [CAS 56390-09-1]
|
|
|
|
HY-13624A-1mL
|
MedChemexpress LLC
|
Epirubicin hydrochloride [CAS 56390-09-1] (10 mM in DMSO)
|
|
|
|
HY-15359-1mg
|
MedChemexpress LLC
|
Episilvestrol [CAS 697235-39-5]
|
|
|
|
HY-15359-1mL
|
MedChemexpress LLC
|
Episilvestrol [CAS 697235-39-5] (10 mM in DMSO)
|
|
|
|
HY-N2182-5mg
|
MedChemexpress LLC
|
Episyringaresinol 4'-O-beta-D-glncopyranoside [CAS 137038-13-2]
|
|
|
|
HY-N2182-10mg
|
MedChemexpress LLC
|
Episyringaresinol 4'-O-beta-D-glncopyranoside [CAS 137038-13-2]
|
|
|
|
HY-P1149A-1mg
|
MedChemexpress LLC
|
Epitalon TFA
|
|
|
|
HY-P1149A-5mg
|
MedChemexpress LLC
|
Epitalon TFA
|
|
|
|
HY-P1149A-10mg
|
MedChemexpress LLC
|
Epitalon TFA
|
|
|
|
HY-P1149A-25mg
|
MedChemexpress LLC
|
Epitalon TFA
|
|
|
|
HY-P1149A-1mL
|
MedChemexpress LLC
|
Epitalon TFA (10 mM in DMSO)
|
|
|
|
HY-139300A-5mg
|
MedChemexpress LLC
|
Epitinib succinate [CAS 2252334-12-4]
|
|
|
|
HY-139300A-10mg
|
MedChemexpress LLC
|
Epitinib succinate [CAS 2252334-12-4]
|
|
|
|
HY-139300A-25mg
|
MedChemexpress LLC
|
Epitinib succinate [CAS 2252334-12-4]
|
|
|
|
HY-139300A-50mg
|
MedChemexpress LLC
|
Epitinib succinate [CAS 2252334-12-4]
|
|
|
|
HY-139300A-100mg
|
MedChemexpress LLC
|
Epitinib succinate [CAS 2252334-12-4]
|
|
|
|
HY-B0251-10mg
|
MedChemexpress LLC
|
Eplerenone [CAS 107724-20-9]
|
|
|
|
HY-B0251-50mg
|
MedChemexpress LLC
|
Eplerenone [CAS 107724-20-9]
|
|
|
|
HY-B0251-100mg
|
MedChemexpress LLC
|
Eplerenone [CAS 107724-20-9]
|
|
|
|
HY-B0251-1mL
|
MedChemexpress LLC
|
Eplerenone [CAS 107724-20-9] (10 mM in DMSO)
|
|
|
|
HY-10792A-5mg
|
MedChemexpress LLC
|
Eplivanserin (mixture) [CAS 130581-13-4]
|
|
|
|
HY-10792A-10mg
|
MedChemexpress LLC
|
Eplivanserin (mixture) [CAS 130581-13-4]
|
|
|
|
HY-10792A-50mg
|
MedChemexpress LLC
|
Eplivanserin (mixture) [CAS 130581-13-4]
|
|
|
|
HY-10792A-100mg
|
MedChemexpress LLC
|
Eplivanserin (mixture) [CAS 130581-13-4]
|
|
|
|